N'-(3-BENZYL-4-OXO-1,3-THIAZOLIDIN-2-YLIDENE)-2-(1,3-DIMETHYL-2,6-DIOXO-1,2,3,6-TETRAHYDRO-7H-PURIN-7-YL)ACETOHYDRAZIDE
UNII U2YMX35QFQ
Substance Identification & Data
This profile provides standardized clinical and technical data for N'-(3-benzyl-4-oxo-1,3-thiazolidin-2-ylidene)-2-(1,3-dimethyl-2,6-dioxo-1,2,3,6-tetrahydro-7h-purin-7-yl)acetohydrazide, uniquely identified by the FDA Unique Ingredient Identifier (UNII) U2YMX35QFQ.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 70863-03-5 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C19H19N7O4S OLGYNBRBCTUXJA-RELWKKBWSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for N'-(3-benzyl-4-oxo-1,3-thiazolidin-2-ylidene)-2-(1,3-dimethyl-2,6-dioxo-1,2,3,6-tetrahydro-7h-purin-7-yl)acetohydrazide. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.